Inflammatory Biomarker,Neopterin,Suppresses B Lymphopoiesis for Possible Facilitation of Granulocyte Responses,Which Is Severely Altered in Age-Related Stromal-Cell

Abstract

Neopterin is produced by monocytes and is a useful biomarker of inflammatory activation. We found that neopterin enhanced in vivo and in vitro granulopoiesis triggered by the stromal-cell production of cytokines in mice. The effects of neopterin on B lymphopoiesis during the enhancement of granulopoiesis were determined using the mouse model of senescent stromal-cell impairment (SCI), a subline of senescence-accelerated mice (SAM). In non-SCI mice (a less senescent stage of SCI mice), treatment with neopterin decreased the number of colonies, on a semisolid medium, of colony-forming units of pre–B-cell progenitors (CFU-preB) from unfractionated bone marrow (BM) cells, but not that from a population rich in pro-B and pre-B cells without stromal cells. Neopterin upregulated the expression of genes for the negative regulators of B lymphopoiesis such as tumor necrosis factor-α (TNF-α ), interleukin-6 (IL-6), and transforming growth factor-β (TGF-β) in cultured stromal cells, implying that neopterin suppressed the CFU-preB colony formation by inducing negative regulators from stromal cells. The intraperitoneal injection of neopterin into non-SCI mice resulted in a marked decrease in the number of femoral CFU-preB within 1 day, along with increases in TNF-α and IL-6 expression levels. However, in SCI mice, in vivo and in vitro responses to B lymphopoiesis and the upregulation of cytokines after neopterin treatment were less marked than those in non-SCI mice. These results suggest that neopterin predominantly suppressed lymphopoiesis by inducing the production of negative regulators of B lymphopoiesis by stromal cells, resulting in the selective suppression of in vivo B lymphopoiesis. These results also suggest that neopterin facilitated granulopoiesis in BM by suppressing B lymphopoiesis, thereby contributing to the potentiation of the inflammatory process; interestingly, such neopterin function became impaired during senescence because of attenuated stromal-cell function, resulting in the downmodulation of the host-defense mechanism in the aged.

Get full access to this article

View all access options for this article.

References

Rembold H, Gyure WL. Biochemistry of the pteridines. Angew Chem Int Ed Engl 11:1061–1072, 1972.

Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter N. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 160:310–316, 1984.

Niederwieser D, Huber C, Gratwohl A, Bannert P, Fuchs D, Hausen A, Reinbnegger G, Speck B, Wachter H. Neopterin as a new biochemical marker in the clinical monitoring of bone marrow transplant recipients. Transplantation 38:497–500, 1984.

Reibnegger G, Aulitzky W, Huber C, Margreoter R, Riccabona G, Wachter H. Neopterin in urine and serum of renal allograft recipients. J Clin Chem Biochem 24:770–775, 1986.

Schobersberger W, Hoffmann G, Hobisch-Hagen P, Bock G, Volkl H, Baier-Bitterlich G, Wirleitner B, Wachter H, Fuchs D. Neopterin and 7,8-dihydroneopterin induce apoptosis in the rat alveolar epithelial cell line L2. FEBS Lett 397:263–268, 1996.

Kojima S, Nomura T, Icho T, Kajiwara Y, Kitabatake K, Kubota K. Inhibitory effect of neopterin on NADPH-dependent superoxide-generating oxidase of rat peritoneal macrophages. FEBS Lett 329: 125–128, 1993.

Schobersberger W, Jelkmann W, Fandrey J, Frede S, Wachter H, Fuchs D. Neopterin-induced suppression of erythropoietin production in vitro. Pteridines 6:12–16, 1995.

Uberall F, Werner-Felmayer G, Schubert C, Grunicke HH, Wachter H, Fuchs D. Neopterin derivatives together with cyclic guanosine monophosphate induce c-fos gene expression. FEBS Lett 352:11–14, 1994.

Schobersberger W, Hoffmann G, Grote J, Wachter H, Fuchs D. Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells. FEBS Lett 377:461–464, 1995.

10.

Kibourn RG, Traber DL, Szabo C. Nitric oxide and shock. Dis Mon 43: 277–348, 1997.

11.

Aizawa S, Hiramoto M, Araki S, Negishi S, Kimura Y, Hoshi G, Kojima S, Wakasugi K. Stimulatory effects of neopterin on hematopoiesis in vitro are mediated by activation of stromal-cell function. Hematol Oncol 16:57–67, 1998.

12.

Aizawa S, Hamamoto H, Araki S, Hoshi H, Kojima S, Wakasugi K. In vivo stimulatory effects of neopterin on hematopoiesis. Pteridines 9:13–17, 1998.

13.

Takeda T, Hosokawa M, Takeshita S, Irino M, Higuchi K, Matsushita T, Tomita Y, Yasuhira K, Hamamoto H, Shimizu K, Ishii M, Yamamuro T. A new murine model of accelerated senescence. Mech Ageing Dev 17:183–194, 1981.

14.

Izumi-Hisha H, Ito Y, Sugimoto K, Oshima H, Mori KJ. Age-related decrease in the number of hemopoietic stem cells and progenitors in senescence accelerated mice. Mech Ageing Dev 56:89–97, 1990.

15.

Tsuboi I, Morimoto K, Horie T, Mori KJ. Age-related changes in various hemopoietic progenitor cells in senescence-accelerated (SAMP) mice. Exp Hematol 19:874–877, 1991.

16.

Tsuboi I, Morimoto K, Hirabayashi Y, Li GX, Aizawa S, Mori KJ, Kanno J, Inoue T. Senescent B lymphopoiesis is balanced in suppressive homeostasis: decrease in interleukin-7 and transforming growth factor-β levels in stromal-cells of senescence-accelerated mice. Exp Biol Med (Maywood) 229:494–502, 2004.

17.

Riley RL, Kruger MG, Elia J. B cell precursors are decreased in senescent BALB/c mice, but retain normal mitotic activity in vivo and in vitro. Clin Immunol Immunopathol 59:301–313, 1991.

18.

Fuchs D, Stahl-Hennig C, Gruber A, Murr C, Hunsmann G, Wachter H. Neopterin—its clinical use in urinalysis. Kidney Int Suppl 47:S8–S11, 1994.

19.

Nagaoka H, Gonzalez-Aseguinolaza G, Tsuji M, Nussenzweig MC. Immunization and infection change the number of recombination activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production. J Exp Med 191:2113–2120, 2000.

20.

Ueda Y, Yang K, Foster SJ, Kondo M, Kelsoe G. Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J Exp Med 199:47–58, 2004.

21.

Ueda Y, Kondo M, Kelsoe G. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med 201:1771–1780, 2005.

22.

Wirleitner B, Obermoser G, Bock G, Neurauter G, Schennach H, Sepp N, Fuchs D. Induction of apoptosis in human blood T cells by 7,8-dihydroneopterin: the difference between healthy controls and patients with systemic lupus erythematosus. Clin Immunol 107:152–159, 2003.

23.

Nemunaitis J, Tompkins CK, Andrews DF, Singer JW. Transforming growth factor beta expression in human marrow stromal-cells. Eur J Haematol 46:140–145, 1991.

24.

Hoffman G, Schobersberger W, Frede S, Pelzer L, Fandrey J, Wachter H, Fuchs D, Grote J. Neopterin activates transcription factor nuclear factor-κB in vascular smooth muscle cells FEBS Lett 391:181–184, 1996.

25.

Hoffman G, Kenn S, Wirleitner B, Deetjen C, Trede S, Smolny M, Rieder J, Fuchs D, Baier-Bitterlich G, Schobersberger W. Neopterin induces nitric oxide-dependent apoptosis in rat vascular smooth muscle cells. Immunobiol 199:63–73, 1998.

26.

Lee G, Namen AE, Gillis S, Ellingsworth LR, Kincade PW. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta. J Immunol 142:3875–3883, 1989.

27.

Fernandez S, Knopf MA, Shankar G, McGillis JP. Calcitonin gene-related peptide indirectly inhibits IL-7 responses in pre-B cells by induction of IL-6 and TNF-alpha in bone marrow. Cell Immunol 226: 67–77, 2003.

28.

Barak M, Gruener N. Neopterin augmentation of tumor necrosis factor production. Immunol Lett 30:101–106, 1991.

29.

Hoffmann G, Frede S, Kenn S, Smolny M, Wachter H, Fuchs D, Grote J, Rieder J, Schobersberger W. Neopterin-induced tumor necrosis factor-alpha synthesis in vascular smooth muscle cells in vitro. Int Arch Allergy Immunol 116:240–245, 1998.

30.

Nakamura K, Kouro T, Kincade PW, Malykhin A, Maeda K, Coggeshall KM. Src homology 2-containing 5-inositol phosphatase (SHIP) suppresses an early stage of lymphoid cell development through elevated interleukin-6 production by myeloid cells in bone marrow. J Exp Med 199:243–254, 2004.

31.

Maeda K, Baba Y, Nagai Y, Miyazaki K, Malykhin A, Nakamura K, Kincade PW, Sakaguchi N, Coggeshall KM. IL-6 blocks a discrete early step in lymphopoiesis. Blood 106:879–885, 2005.

32.

Saito H, Sherwood ER, Varma TK, Evers BM. Effect of aging on mortality, hypothermia, and cytokine induction in mice with endotoxemia or sepsis. Mech Ageing Dev 124:1047–1058, 2003.

33.

Tateda K, Matsumoto T, Miyazaki S, Yamaguchi K. Lipopolysaccharide-induced lethality and cytokine production in aged mice. Infect Immun 64:769–774, 1996.

Inflammatory Biomarker,Neopterin,Suppresses B Lymphopoiesis for Possible Facilitation of Granulocyte Responses,Which Is Severely Altered in Age-Related Stromal-Cell–Impaired Mice,SCI/SAM

Abstract

Get full access to this article

References